Category Archives: Anti-counterfeiting

IOM: Curb Fake Meds through Track-and-Trace, but Forget "Counterfeits"

By Jill Wechsler | Published: February 19, 2013

A new report from the Institute of Medicine (IOM) has drawn a lot of attention to the public health dangers of falsified and substandard medicines around the world. The aim is to build support for a range of activities that can limit the spread of fake medicines in the U.S. and help developing nations strengthen [...]

Also posted in Events, FDA, Manufacturing, R&D, Regulatory, Safety, Strategy, Supply Chain, compliance | Tagged Institute of Medicine, IOM, National Institute of Standards and Technology, NIST, Public health, Supply Chain | Leave a comment

FDA Finding Fuels Indian Crackdown on Sub-standard Drugs

By Guest Blogger | Published: July 27, 2011

By Mangesh Sai, Asia Correspondent. A routine monthly inspection carried out by the Food and Drugs Administration (FDA) authorities in the state of Maharashtra, India, last month noted an increase in the number of sub-standard drug samples raising apprehensions about the availability of safe and genuine drugs in the state. Officials pointed out that 26 drug samples [...]

Also posted in Global, Guest Blog, IP, Safety | Tagged Emerging Markets, EU, FDA, india, sub-standard drugs | Leave a comment